Sign In
Buy MEDS
$7.59
+0 (+0%)
At Close: Dec 19, 2024
TRxADE (MEDS) Reports Q4 Loss, Tops Revenue Estimates
07:47pm, Monday, 27'th Mar 2023
TRxADE (MEDS) delivered earnings and revenue surprises of -66.67% and 8.54%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
TRxADE HEALTH, INC. to Report Q4 and Year-End 2022 Financial Results on Monday, March 27th at 5:30 p.m.
04:00pm, Monday, 13'th Mar 2023
TAMPA, FL / ACCESSWIRE / March 13, 2023 / TRxADE HEALTH INC. (NASDAQ:MEDS) , is a health services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the
All You Need to Know About TRxADE (MEDS) Rating Upgrade to Strong Buy
01:33pm, Thursday, 12'th Jan 2023
TRxADE (MEDS) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
All You Need to Know About TRxADE (MEDS) Rating Upgrade to Buy
01:32pm, Thursday, 17'th Nov 2022
TRxADE (MEDS) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
7 Meme Stocks Smart Investors Shouldn't Touch With a 10-Foot Pole
11:43am, Wednesday, 09'th Nov 2022
Meme stocks represented one of the most remarkable developments in the equities space during much of the new normal. However, by 2022, this sector received a very rude awakening.
TRxADE Health, Inc. (MEDS) Q3 2022 Earnings Call Transcript
12:42am, Tuesday, 08'th Nov 2022
TRxADE Health, Inc. (NASDAQ:MEDS ) Q3 2022 Earnings Conference Call November 7, 2022 5:00 PM ET Company Participants Janet Huffman - CFO & Principal Accounting Officer Surendra Ajjarapu - Founder, Cha
TRxADE (MEDS) Reports Q3 Loss, Lags Revenue Estimates
08:19pm, Monday, 07'th Nov 2022
TRxADE (MEDS) delivered earnings and revenue surprises of 50% and 27.05%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
TRxADE HEALTH, INC. to Report Third Quarter 2022 Financial Results on Monday, November 7th at 5:00 p.m.
03:30pm, Monday, 24'th Oct 2022
TAMPA, FL / ACCESSWIRE / October 24, 2022 / TRxADE HEALTH INC. (NASDAQ:MEDS) , is a health services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, th
3 High Volume Penny Stocks To Watch Before FOMC Meeting
03:27pm, Tuesday, 20'th Sep 2022
High volume penny stocks for your September watch list. The post 3 High Volume Penny Stocks To Watch Before FOMC Meeting appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStock
TRxADE HEALTH, Inc.'s (MEDS) CEO Suren Ajjarapu on Q2 2022 Results - Earnings Call Transcript
10:10pm, Monday, 25'th Jul 2022
TRxADE HEALTH, Inc. (NASDAQ:MEDS ) Q2 2022 Earnings Conference Call July 25, 2022 5:00 PM ET Company Participants Suren Ajjarapu - Founder, Chairman and CEO Janet Huffman - Chief Financial Officer Con
TRxADE (MEDS) Reports Q2 Loss, Tops Revenue Estimates
07:20pm, Monday, 25'th Jul 2022
TRxADE (MEDS) delivered earnings and revenue surprises of -44.44% and 13.07%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
TRxADE HEALTH, INC. to Report Second Quarter 2022 Financial Results on Monday, July 25th at 5:00 p.m.
04:30pm, Monday, 11'th Jul 2022
TAMPA, FL / ACCESSWIRE / July 11, 2022 / TRxADE HEALTH INC. (NASDAQ:MEDS) , is a health services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the p
TRxADE HEALTH, Inc. (MEDS) CEO Suren Ajjarapu on Q1 2022 Results - Earnings Call Transcript
08:25pm, Monday, 09'th May 2022
TRxADE HEALTH, Inc. (NASDAQ:MEDS ) Q1 2022 Earnings Conference Call May 9, 2022 5:00 PM ET Company Participants Suren Ajjarapu – Founder, Chairman and Chief Executive Officer Janet Huffman – Chief
TRxADE (MEDS) Reports Q1 Loss, Tops Revenue Estimates
07:33pm, Monday, 09'th May 2022
TRxADE (MEDS) delivered earnings and revenue surprises of -33.33% and 37.87%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Earnings Preview: TRxADE (MEDS) Q1 Earnings Expected to Decline
04:33pm, Monday, 02'nd May 2022
TRxADE (MEDS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
